Nuvectis Pharma Inc (NVCT)

SG&A Expenses

$9.22M

TTM · Period ending: · USD

NVCT logo

NVCT SG&A Expenses

Latest reported$9.22M
NVCT TTM SG&A Expenses ($3.35M → $9.22M)
High-resolution chart · PNG

NVCT sg&a expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Nuvectis Pharma Inc SG&A Expenses — Trailing twelve months (TTM) (USD)
Period endingSG&A Expenses (USD)
9,218,000
9,687,000
9,421,000
8,843,000
8,363,000
7,081,000
6,929,000
7,577,000
7,709,000
7,519,000
7,517,000
7,297,000
7,043,000
6,601,000
6,007,000
4,747,000
3,841,000
4,466,000
3,349,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.